Vapotherm, Inc. (VAPO)

Market Cap	13.05M
Revenue (ttm)	70.07M
Net Income (ttm)	-54.94M
Shares Out	6.22M
EPS (ttm)	-8.72
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,880
Open	2.100
Previous Close	2.110
Day's Range	n/a
52-Week Range	0.700 - 4.100
Beta	-1.16
Analysts	Sell
Price Target	1.00 (-52.38%)
Earnings Date	Nov 8, 2023

About VAPO

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients thro...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Nov 14, 2018
• Employees: 182
• Stock Exchange: OTCMKTS
• Ticker Symbol: VAPO

Financial Performance

In 2023, Vapotherm's revenue was $68.67 million, an increase of 2.80% compared to the previous year's $66.80 million. Losses were -$58.19 million, -48.62% less than in 2022.

Analyst Forecast

According to one analyst, the rating for VAPO stock is "Sell" and the 12-month stock price forecast is $1.0.

Price Target

$1.0

(-52.38% downside)

Analyst Consensus: Sell